What is PTHS's cash & equivalents?

PTHS (PTHS) reported cash & equivalents of $31.98M in Q1 2026.

How has PTHS's cash & equivalents changed year-over-year?

PTHS's cash & equivalents increased by 24250.2% year-over-year, from $131.32K to $31.98M.

What is the long-term trend for PTHS's cash & equivalents?

Over 3 years (2022 to 2025), PTHS's cash & equivalents has grown at a 588.5% compound annual growth rate (CAGR), from $55.07K to $17.97M.

What does cash & equivalents mean?

Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.

PTHS PTHS Cash & Equivalents

Cash & Equivalents at other companies

Cumberland PharmaceuticalsCPIX

$11.01M-27.1%

Journey Medical CorporationDERM

$27.22M+29.2%

Zevra Therapeutics, Inc.ZVRA

$95.6M+156%

Theravance BiopharmaTBPH

$288.1M+160%

HRO

HarrowHROW

$94.64M+41.8%

Ocular TherapeutixOCUL

$666.7M+90.7%

Other financials

Income statement

See full

Revenue$10.9M—

Gross profit$9.2M—

Operating income-$13.1M-614%

Net income-$10.2M-420%

EPS (diluted)-$3.09+3.7%

Balance sheet

See full

Total debt$29.6M—

Total equity$35.1M+937%

Total assets$145.4M+15,855%

Cash flow

See full

Operating cash flow-$13.1M-1,977%

CapEx$194.0K—

Free cash flow-$13.3M-2,008%

Valuation

See full

Market cap$98.22M+92.4%

Enterprise value$95.89M—

P/S3.6×—

Profitability

See full

Gross margin79.6%—

Operating margin-157.7%—

Net margin-186.2%—

FCF margin-60.8%—

Returns & leverage

See full

Return on equity-333.8%—

Debt / equity0.8×—

Current ratio2.8×+2.6×

Where this comes from

Reported directly by PTHS in its filing.

Tagged under the XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue.

The official record: PTHS’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about PTHS's cash & equivalents.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is PTHS's cash & equivalents?: PTHS (PTHS) reported cash & equivalents of $31.98M in Q1 2026.
How has PTHS's cash & equivalents changed year-over-year?: PTHS's cash & equivalents increased by 24250.2% year-over-year, from $131.32K to $31.98M.
What is the long-term trend for PTHS's cash & equivalents?: Over 3 years (2022 to 2025), PTHS's cash & equivalents has grown at a 588.5% compound annual growth rate (CAGR), from $55.07K to $17.97M.
What does cash & equivalents mean?: Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.